Cancer Biotherapy and Radiopharmaceuticals
| 短名 | Cancer. Biother. Radiopharm. |
| Journal Impact | 2.38 |
| 国际分区 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING(Q2) |
| 期刊索引 | SCI Q2中科院 4 区 |
| ISSN | 1084-9785, 1557-8852 |
| h-index | 68 |
| 国内分区 | 医学(4区)医学医学研究与实验(4区)医学肿瘤学(4区)医学药学(4区)医学核医学(4区) |
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 是成熟的同行评审期刊，拥有超过 25 年关于创新治疗研究的前沿内容，以最终改善癌症管理。它是唯一专注于癌症生物治疗的期刊，包括单克隆抗体、细胞因子治疗、癌症基因治疗、基于细胞的治疗和其他形式的免疫治疗。该杂志广泛报道了放射免疫治疗的进展和使用用于开发新的癌症治疗方法的放射性药物和放射性标记肽。
期刊主页投稿网址| 涉及主题 | 医学生物遗传学内科学化学生物化学癌症研究癌症免疫学病理外科体外物理基因放射科核医学肿瘤科细胞培养有机化学生物技术细胞凋亡体内 |
| 出版信息 | 出版商: Mary Ann Liebert Inc.，出版周期: Bimonthly，期刊类型: journal |
| 基本数据 | 创刊年份: 1996，原创研究文献占比: 100.00%，自引率:0.00%， Gold OA占比: 5.17% |
| 平均审稿周期 | 网友分享经验：平均3月 |
| 平均录用比例 | 网友分享经验：约95% |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Searching for Protein Off-Targets of Prostate-Specific Membrane Antigen-Targeting Radioligands in the Salivary Glands
2024-9-13
Synthesis, Preclinical Toxicity, and Biodistribution of [<sup>18</sup>F]AVT-011 to Assess the P-Glycoprotein Function
2024-9-12
METTL3-Mediated m<sup>6</sup>A Modification of FMRP Drives Hepatocellular Carcinoma Progression and Indicates Poor Prognosis
2024-9-12
Colorectal Cancer-Derived Exosomes Impair CD4<sup>+</sup> T Cell Function and Accelerate Cancer Progression via Macrophage Activation
2024-9-12
Baseline <sup>18</sup>F-FDG PET Radiomics Predicting Therapeutic Efficacy of Diffuse Large B-Cell Lymphoma after R-CHOP (-Like) Therapy
2024-9-4
WT1 And DNMT3A Mutations in Prognostic Significance of Acute Myeloid Leukemia: A Meta-Analysis
2024-8-29
A Comprehensive Analysis of LYAR in Colorectal Cancer: Prognostic Marker and Therapeutic Target
2024-8-19
Development in the Study of Natural Killer Cells for Malignant Peritoneal Mesothelioma Treatment
2024-8-2
Evaluation of <i>5′-tRF-His-GTG</i> As a Molecular Biomarker in Breast Cancer Diagnoses and Prognosis
2024-8-1
Pyrotinib and Trastuzumab Plus Chemotherapy Serve as an Acceptable Neoadjuvant Regimen Exhibiting Good Efficacy and Tolerance in HER2-Positive Breast Cancer Patients
2024-8-1
Human Biodistribution and Radiation Dosimetry of the Targeting Fibroblast Growth Factor Receptor 1-Positive Tumors Tracer [<sup>68</sup>Ga]Ga-DOTA-FGFR1-Peptide
2024-7-18
Advancing Cancer Theranostics Through Integrin αVβ3-Targeted Peptidomimetic IAC: From Bench to Bedside
2024-7-8
Long Noncoding RNA CRNDE Promotes Gastric Cancer Progression through Targeting miR-136-5p/MIEN1
2024-7-4
Hsa_Circ_002144 Promotes Glycolysis and Immune Escape of Breast Cancer Through miR-326/PKM Axis
2024-7-4
microRNA-106b-5p and Rab10: Potential Markers of Acute Myeloid Leukemia
2024-7-1
Stratification of Lung Adenocarcinoma Patients Based on <i>In Silico</i> and Immunohistochemistry Analyses of Oxidative Stress-Related Genes
2024-7-1
GRHPR, Targeted by miR-138-5p, Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Through PI3K/AKT Signaling Pathway
2024-6-27
Immune Response to Molecular Radiotherapy with <sup>177</sup>Lu-DOTATOC: Predictive Value of Blood Cell Counts for Therapy Outcome
2024-6-21
Unlocking Clinical Insights: Lymphocyte-Specific Protein Tyrosine Kinase Candidates as Promising Therapeutic Targets for Pancreatic Cancer Risk Stratification
2024-6-5
Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging
2024-6-3
Assessment of DNA/RNA Deregulation in Cancer Using <sup>99m</sup>Tc-Labeled Thiopurine
2024-6-1
Enhanced Tumor Targeting of Radiolabeled Mouse/Human Chimeric Anti-Tn Antibody in Losartan-Treated Mice Bearing Tn-Expressing Lung Tumors
2024-6-1
The Role of [<sup>18</sup>F]FDG PET/CT in the Characterization of Thymic Epithelial Tumors at Initial Stage
2024-6-1
Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on <sup>90</sup>Y Selective Internal Radiation Therapy Planning
2024-6-1
Re: “Evaluating the Diagnostic Efficacy of <sup>99m</sup>Tc-Methionine Single-Photon Emission Computed Tomography–Computed Tomography: A Head-to-Head Comparison with <sup>11</sup>C-Methionine Positron Emission Tomography–Magnetic Resonance Imaging in Glioma Patients” by Kumar et al.
2024-6-1
Value of Semi-Quantitative Parameters of <sup>68</sup>Ga-FAPI-04 PET/CT in Primary Malignant and Benign Diseases: A Comparison with <sup>18</sup>F-FDG
2024-5-29
Theranostics: Timing is Everything
2024-5-17
GSK-3: An “Ace” Among Kinases
2024-5-15
TGF-β Promotes Hepatocellular Carcinoma Metastasis Through Through m6A Modification of PCDHGA9
2024-5-10
A New Perspective on the Effectiveness of FDG PET/CT in Predicting KRAS Mutation in Colon Cancer Cases
2024-5-10
Molecular Breast Imaging of HER2-Positive Breast Cancer in the Era of PHERGain Trial: The past, the Present, and the Prospects
2024-5-3
A Prognostic Model for Prostate Cancer Patients Based on Two DNA Damage Response Mutation-Related Immune Genes
2024-5-1
IL-6 Accelerates the Proliferation and Metastasis of Pancreatic Cancer Cells via the miR-455-5p/IGF-1R Axis
2024-5-1
Long Non-Coding RNA AC008972.1 as a Novel Therapeutic Target for Prostate Cancer
2024-5-1
Promising Therapeutic Targets in Kidney Renal Clear Cell Carcinoma: <i>PLXNA1</i> and <i>PLXNB3</i>
2024-5-1
Short-Term Biological Toxicity Prediction of [<sup>177</sup>Lu]Lutetium-Oxodotreotide: An Original Retrospective Analysis
2024-4-24
LncRNA EBLN3P Accelerates Cell Proliferation and Invasion of Colon Cancer through Modulating the miR-519d-3p/ZFP91 Axis
2024-4-10
Knockdown of <i>BUB1B</i> Inhibits the Proliferation, Migration, and Invasion of Colorectal Cancer by Regulating the JNK/c-Jun Signaling Pathway
2024-4-1
Lipiodol as a Predictive Indicator for Therapy Response to Transarterial Chemoembolization of Hepatocellular Carcinoma
2024-4-1
Knockdown of lncRNA SNHG20 Suppressed the Proliferation of Cholangiocarcinoma by Sponging miR-520f-3p
2024-4-1
Curcumol Inhibits the Progression of Hepatocellular Carcinoma by Regulating the Expression of hsa_circ_0028861
2024-4-1
<i>TIGD1</i> Is an Independent Prognostic Factor that Promotes the Progression of Colon Cancer
2024-4-1
Predicting the Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Using Soluble Immune Checkpoints
2024-4-1
The Regulatory Role of <i>SNORD35A</i> in Pancreatic Cancer Involves the HGF/C-Met Pathway
2024-4-1
Unraveling Interaction of Rhenium-188 Microspheres with Primary Hepatic Cancer Cell: A Breakthrough Study
2024-4-1
Exosome-Derived MicroRNA-221-3p Desensitizes Breast Cancer Cells to Adriamycin by Regulating <i>PIK3r1</i>-Mediated Glycose Metabolism
2024-3-26
Participation of Long Noncoding RNA <i>FOXP4-AS1</i> in the Development and Progression of Endometrioid Carcinoma with Epigenetically Silencing <i>DUSP5</i>
2024-3-21
Prognostic Signature in Osteosarcoma Based on Amino Acid Metabolism-Associated Genes
2024-3-21
The Survival Benefit of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in the Management of Breast Cancer
2024-3-21
Efficacy of Everolimus Combined with <sup>177</sup>Lu-Dotatate in the Treatment of Neuroendocrine Tumors
2024-3-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远